Echocardiographic Abnormalities in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Patients

被引:9
作者
Pfeferman, Mariana Becker [1 ,2 ]
da Rocha, Daniel Ribeiro [2 ]
Rodrigues, Fernanda Guedes [3 ]
Pfeferman, Elcio [4 ]
Heilberg, Ita Pfeferman [2 ]
机构
[1] Univ Santo Amaro UNISA, Med Sch, BR-04829300 Sao Paulo, SP, Brazil
[2] Univ Fed Sao Paulo UNIFESP, Nephrol Div, BR-04023062 Sao Paulo, Brazil
[3] Univ Fed Sao Paulo UNIFESP, Nutr Post Grad Program, BR-04023062 Sao Paulo, Brazil
[4] Hosp Israelita Albert Einstein HIAE, BR-05652900 Sao Paulo, Brazil
关键词
ADPKD; cardiovascular; echocardiogram; left ventricular mass index; mitral valve prolapse; polycystic disease; valvar abnormalities; MITRAL-VALVE-PROLAPSE; LEFT-VENTRICULAR HYPERTROPHY; NATIVE VALVULAR REGURGITATION; CARDIOVASCULAR-ABNORMALITIES; DIASTOLIC FUNCTION; BLOOD-PRESSURE; YOUNG-ADULTS; NORMOTENSIVE PATIENTS; EUROPEAN ASSOCIATION; AMERICAN SOCIETY;
D O I
10.3390/jcm11205982
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular abnormalities, such as left ventricular hypertrophy and valvular disorders, particularly mitral valve prolapse, have been described as highly prevalent among adult patients with autosomal dominant polycystic kidney disease (ADPKD). The present study aimed to assess echocardiographic parameters in a large sample of both normotensive and hypertensive ADPKD patients, regardless of kidney function level, and evaluate their association with clinical and laboratorial parameters. A retrospective study consisted of the analysis of clinical, laboratorial, and transthoracic echocardiograms data retrieved from the medical records of young adult ADPKD outpatients. A total of 294 patients (120 M/174 F, 41.0 +/- 13.8 years old, 199 hypertensive and 95 normotensive) with a median estimated glomerular filtration rate (eGFR) of 75.5 mL/min/1.73 m(2) were included. The hypertensive group (67.6%) was significantly older and exhibited significantly lower eGFR than the normotensive one. Increased left ventricular mass index (LVMI) was seen in 2.0%, mitral valve prolapse was observed in 3.4%, mitral valve regurgitation in 15.3%, tricuspid valve regurgitation in 16.0%, and aortic valve regurgitation in 4.8% of the whole sample. The present study suggested that the prevalence of mitral valve prolapse was much lower than previously reported, and increased LVMI was not seen in most adult ADPKD patients.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Epicardial Fat Thickness in Patients with Autosomal Dominant Polycystic Kidney Disease
    Concistre, Antonio
    Petramala, Luigi
    Scoccia, Gianmarco
    Sciomer, Susanna
    Bisogni, Valeria
    Saracino, Vincenza
    Lannucci, Gino
    Lai, Silvia
    Mastroluca, Daniela
    Lacobellis, Gianluca
    Letizia, Claudio
    CARDIORENAL MEDICINE, 2018, 8 (03) : 199 - 207
  • [22] European ADPKD Forum multidisciplinary position statement on autosomal dominant polycystic kidney disease care
    Harris, Tess
    Sandford, Richard
    de Coninck, Brenda
    Devuyst, Olivier
    Drenth, Joost P. H.
    Ecder, Tevfik
    Kent, Alastair
    Gansevoort, Ron T.
    Gorriz, Jose Luis
    Ong, Albert C. M.
    Pirson, Yves
    Torres, Vicente E.
    Budde, Klemens
    Clement, Denis
    Derchi, Lorenzo E.
    Eleftheroudi, Marianna
    Levtchenko, Elena
    Peters, Dorien
    Van Poppel, Hendrik
    Vanholder, Raymond
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 (04) : 563 - 573
  • [23] Extra-renal manifestations of autosomal dominant polycystic kidney disease (ADPKD): considerations for routine screening and management
    Luciano, Randy L.
    Dahl, Neera K.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (02) : 247 - 254
  • [24] Management of Hypertension and Associated Cardiovascular Disease in Autosomal Dominant Polycystic Kidney Disease
    Rahbari-Oskoui, Frederic F.
    ADVANCES IN KIDNEY DISEASE AND HEALTH, 2023, 30 (05): : 417 - 428
  • [25] Native Nephrectomy before and after Renal Transplantation in Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
    Maxeiner, Andreas
    Bichmann, Anna
    Oberlaender, Natalie
    El-Bandar, Nasrin
    Suguenes, Nesrin
    Ralla, Bernhard
    Biernath, Nadine
    Liefeldt, Lutz
    Budde, Klemens
    Giessing, Markus
    Schlomm, Thorsten
    Friedersdorff, Frank
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (10)
  • [26] Clinical Utility and Tolerability of Tolvaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
    Raina, Rupesh
    Houry, Ahmad
    Rath, Pratik
    Mangat, Guneive
    Pandher, Davinder
    Islam, Muhammad
    Khattab, Ala'a Grace
    Kalout, Joseph K.
    Bagga, Sumedha
    DRUG HEALTHCARE AND PATIENT SAFETY, 2022, 14 : 147 - 159
  • [27] Liver manifestations in autosomal dominant polycystic kidney disease (ADPKD) and their impact on quality of life
    Arjune, Sita
    Todorova, Polina
    Bartram, Malte P.
    Grundmann, Franziska
    Mueller, Roman-Ulrich
    CLINICAL KIDNEY JOURNAL, 2025, 18 (01)
  • [28] The Treatment of Autosomal Dominant Polycystic Kidney Disease
    Kuehn, E. Wolfgang
    Walz, Gerd
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2015, 112 (51-52): : 884 - 890
  • [29] Subclinical metabolic and cardiovascular abnormalities in autosomal dominant polycystic kidney disease
    Chirumamilla, Radha
    Mina, Diana
    Siyahian, Salpi
    Park, Meyeon
    CLINICAL NEPHROLOGY, 2018, 90 (04) : 237 - 245
  • [30] Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease
    Walz, Gerd
    Budde, Klemens
    Mannaa, Marwan
    Nuernberger, Jens
    Wanner, Christoph
    Sommerer, Claudia
    Kunzendorf, Ulrich
    Banas, Bernhard
    Hoerl, Walter H.
    Obermueller, Nicholas
    Arns, Wolfgang
    Pavenstaedt, Hermann
    Gaedeke, Jens
    Buechert, Martin
    May, Christoph
    Gschaidmeier, Harald
    Kramer, Stefan
    Eckardt, Kai-Uwe
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (09) : 830 - 840